EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Repopulation of decellularized organ scaffolds with human pluripotent stem cell-derived pancreatic progenitor cells

Saik-Kia Goh, Suzanne Bertera iD, Thomas Richardson, Ipsita Banerjee iD

Biomedical Materials · 01.03.2023 · 18 (2) · 025018

DOI: 10.1088/1748-605x/acb7bf ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Materials, online erschienen am 17.02.2023. Verfasst von Saik-Kia Goh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States of America. Hauptthemen laut MEDLINE: Pluripotent Stem Cells, Islets of Langerhans, Diabetes Mellitus. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NSF, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes is an emerging global epidemic that affects more that 285 million people worldwide. Engineering of endocrine pancreas tissue holds great promise for the future of diabetes therapy. Here we demonstrate the feasibility of re-engineering decellularized organ scaffolds using regenerative cell source. We differentiated human pluripotent stem cells (hPSC) toward pancreatic progenitor (PP) lineage and repopulated decellularized organ scaffolds with these hPSC-PP cells. We observed that hPSCs cultured and differentiated as aggregates are more suitable for organ repopulation than isolated single cell suspension. However, recellularization with hPSC-PP aggregates require a more extensive vascular support, which was found to be superior in decellularized liver over the decellularized pancreas scaffolds. Upon continued culture for nine days with chemical induction in the bioreactor, the seeded hPSC-PP aggregates demonstrated extensive and uniform cellular repopulation and viability throughout the thickness of the liver scaffolds. Furthermore, the decellularized liver scaffolds was supportive of the endocrine cell fate of the engrafted cells. Our novel strategy to engineer endocrine pancreas construct is expected to find potential applications in preclinical testing, drug discovery and diabetes therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pluripotent Stem CellsIslets of LangerhansDiabetes MellitusHumansTissue ScaffoldsPancreasTissue EngineeringExtracellular Matrix

Stichwörter der Autor:innen

decellularizeddecellularized organhuman pluripotent stem cellorganscaffolds

Autor:innen und Institutionen

  • Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States of America.
  • Institute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, United States of America.
  • Department of Chemical and Petroleum Engineering, University of Pittsburgh, Pittsburgh, PA, United States of America.
  • McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA, United States of America.

ORCID-Profile: Suzanne Bertera, Ipsita Banerjee

Förderung

  • NSF
  • National Science Foundation

Zitieren

APA

Goh, S. K., Bertera, S., Richardson, T., & Banerjee, I. (2023). Repopulation of decellularized organ scaffolds with human pluripotent stem cell-derived pancreatic progenitor cells. Biomedical Materials, 18(2), 025018. https://doi.org/10.1088/1748-605x/acb7bf

Vancouver

Goh SK, Bertera S, Richardson T, Banerjee I. Repopulation of decellularized organ scaffolds with human pluripotent stem cell-derived pancreatic progenitor cells. Biomedical Materials. 2023;18(2):025018. doi:10.1088/1748-605x/acb7bf

BibTeX
@article{Goh2023,
  author = {Goh, Saik-Kia and Bertera, Suzanne and Richardson, Thomas and Banerjee, Ipsita},
  title = {Repopulation of decellularized organ scaffolds with human pluripotent stem cell-derived pancreatic progenitor cells},
  journal = {Biomedical Materials},
  year = {2023},
  volume = {18},
  number = {2},
  pages = {025018},
  doi = {10.1088/1748-605x/acb7bf}
}
Kostenlos starten →